The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.
MFS Emerging Markets Debt I MEDIX
- NAV / 1-Day Return 12.28 / −0.35 %
- Total Assets 7.4 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.810%
- Distribution Fee Level Average
- Share Class Type Institutional
- Category Emerging Markets Bond
- Credit Quality / Interest Rate Sensitivity Low/Extensive
- Min. Initial Investment 0
- Status Open
- TTM Yield 6.78%
- Effective Duration 6.90 years
USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0
Morningstar’s Analysis MEDIX
Will MEDIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 14.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Currency Cash CASH_USD | 6.31 | 458.1 Mil | Cash and Equivalents |
United States Treasury Notes 2.75% | 2.89 | 209.9 Mil | Government |
5 Year Treasury Note Future Dec 24 | 2.80 | 203.4 Mil | Government |
USD/EUR FWD 20241018 Purchased | 2.73 | 198.4 Mil | Derivative |
EUR/USD FWD 20241018 Purchased | 2.23 | 161.7 Mil | Derivative |
UST Bond 30Yr Future DEC 19 24 | 1.64 | 118.9 Mil | Government |
10 Year Treasury Note Future Dec 24 | 1.49 | 108.2 Mil | Government |
Oman (Sultanate Of) 6.75% | 1.41 | 102.5 Mil | Government |
USD/BRL NDF 20240927 Purchased | 1.40 | 101.7 Mil | Derivative |
Oman (Sultanate Of) 7% | 1.24 | 89.9 Mil | Government |